Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.
about
Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Combination treatment of docos ...... -remitting multiple sclerosis.
@en
Combination treatment of docosahexaenoic acid
@nl
type
label
Combination treatment of docos ...... -remitting multiple sclerosis.
@en
Combination treatment of docosahexaenoic acid
@nl
prefLabel
Combination treatment of docos ...... -remitting multiple sclerosis.
@en
Combination treatment of docosahexaenoic acid
@nl
P2093
P2860
P1476
Combination treatment of docos ...... g-remitting multiple sclerosis
@en
P2093
Abdorreza Naser Moghadasi
Ali Akbar Saboor-Yaraghi
Ateke Mousavi Nasl-Khameneh
Karim Parastouei
Maryam Mahmoudi
Reza Chahardoli
P2860
P356
10.1080/01616412.2017.1382800
P577
2017-11-18T00:00:00Z